Epigenetic mechanisms in heart development and disease

Drug Discov Today. 2015 Jul;20(7):799-811. doi: 10.1016/j.drudis.2014.12.018. Epub 2015 Jan 6.

Abstract

Suboptimal intrauterine development has been linked to predisposition to cardiovascular disease in adulthood, a concept termed 'developmental origins of health and disease'. Although the exact mechanisms underlying this developmental programming are unknown, a growing body of evidence supports the involvement of epigenetic regulation. Epigenetic mechanisms such as DNA methylation, histone modifications and micro-RNA confer added levels of gene regulation without altering DNA sequences. These modifications are relatively stable signals, offering possible insight into the mechanisms underlying developmental origins of health and disease. This review will discuss the role of epigenetic mechanisms in heart development as well as aberrant epigenetic regulation contributing to cardiovascular disease. Additionally, we will address recent advances targeting epigenetic mechanisms as potential therapeutic approaches to cardiovascular disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Cardiovascular Agents / therapeutic use
  • Chromatin Assembly and Disassembly
  • DNA Methylation
  • Epigenesis, Genetic* / drug effects
  • Gene Expression Regulation, Developmental* / drug effects
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Genetic Therapy
  • Heart / embryology*
  • Heart / growth & development
  • Heart Diseases / embryology
  • Heart Diseases / genetics*
  • Heart Diseases / physiopathology
  • Heart Diseases / therapy
  • Humans
  • MicroRNAs / genetics
  • Morphogenesis / genetics*
  • Phenotype

Substances

  • Cardiovascular Agents
  • Genetic Markers
  • MicroRNAs